Hypervitaminosis D
Reading File
Hypervitaminosis D is a toxic state caused by excessive vitamin D, leading to hypercalcemia and its consequences. Now searching the medical library for detailed information.
Searching sources...
Finding Sources
Finding Sources
Searching PubMed
"hypervitaminosis D" AND "vitamin D toxicity"
Good results found. Now reading the key sections from the most relevant textbooks in parallel.
Reading File
Reading File
Reading File
Finding Sources
Excellent - found rich content across multiple authoritative textbooks. Now reading Harrison's (2025) and Goldman-Cecil for the most up-to-date and comprehensive sections.
Reading File
Reading File
Reading File
Excellent data from Harrison's 2025. Let me now get the treatment details and clinical features from Goldman-Cecil and Tintinalli's Emergency Medicine.
Finding Sources
Finding Sources
I now have comprehensive data from Harrison's, Goodman & Gilman's, Fitzpatrick's, Katzung's, and Goldman-Cecil. Let me compile the full answer.
Hypervitaminosis D
Definition
Hypervitaminosis D (vitamin D intoxication/toxicity) is a state resulting from excessive accumulation of vitamin D or its metabolites, leading primarily to hypercalcemia and hypercalciuria with consequent end-organ damage.
Etiology / Causes
Exogenous (most common):
- Chronic ingestion of high-dose vitamin D supplements (parent D compound, 25(OH)D3, or 1,25(OH)2D3)
- Cod liver oil, herbal medicines containing vitamin D
- Overtreatment of hypoparathyroidism
- "Faddist" use of excessive doses - Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 208
Endogenous (abnormal metabolism):
- Granulomatous diseases: sarcoidosis, tuberculosis, histoplasmosis, coccidiomycosis, leprosy, HIV - unregulated extrarenal 1α-hydroxylase activity in macrophages produces excess 1,25(OH)2D
- Lymphoma
- Williams syndrome - endogenous overproduction of 25(OH)D3
- CYP24A1 (24-hydroxylase) mutations - impaired catabolism of 1,25(OH)2D3
- Infantile hypercalcemia - Harrison's Principles of Internal Medicine 22E (2025), p. 1332
Dose Threshold
The toxic dose varies considerably between individuals:
- Significant hypercalcemia generally requires >10,000 IU/day chronically in otherwise healthy individuals - Harrison's 22E, p. 1331
- As a rough approximation, continued daily ingestion of 50,000 IU/day or more may result in poisoning - Goodman & Gilman's, p. 210
- The tolerable upper intake level is 4,000 IU/day (100 µg/day) for persons >9 years - Yamada's Textbook of Gastroenterology
- Reported cases of toxicity had 25(OH)D levels of 710-1587 nmol/L
Pathophysiology
The primary mechanism is hypercalcemia driven by:
- Increased intestinal calcium absorption - vitamin D (primarily via elevated 25(OH)D) acts on intestinal receptors to enhance calcium and phosphate absorption
- Increased bone resorption - high levels mobilize calcium from bone
- Enhanced renal calcium reabsorption - both calcium and phosphate reabsorption are increased, potentially leading to calciphylaxis - Quick Compendium of Clinical Pathology 5th ed., p. 1076
The key mediator in exogenous toxicity is 25(OH)D (not necessarily 1,25(OH)2D which may not be frankly elevated), because:
- Production of 25(OH)D is less tightly regulated than 1,25(OH)2D
- 25(OH)D has intrinsic, though low-level, biologic activity at intestinal and bone receptors
- Concentrations of 25(OH)D can rise several-fold with excess intake - Harrison's 22E, p. 1333
In granulomatous disease, by contrast, the culprit is excess 1,25(OH)2D produced by macrophage 1α-hydroxylase that lacks the normal negative feedback from calcium/phosphate. TNF and other inflammatory cytokines upregulate both the vitamin D receptor and 1α-hydroxylase in granuloma macrophages.
Clinical Features
Symptoms of hypercalcemia (initial):
| System | Manifestations |
|---|---|
| General | Weakness, lethargy, fatigue |
| CNS | Headache, confusion, depression |
| GI | Nausea, vomiting, anorexia, constipation |
| Renal | Polyuria, polydipsia (nephrogenic DI), nephrolithiasis |
| Cardiovascular | Hypertension, shortened QT interval |
Signs of chronic/severe toxicity:
- Metastatic calcification - deposits in soft tissues, vessel walls, and organs
- Nephrocalcinosis and irreversible renal failure
- Nephrolithiasis
- Subcutaneous calcification, predominantly periarticular - Fitzpatrick's Dermatology, p. 1585
- Band keratopathy (corneal calcification)
- Bone pain and fractures
Diagnosis
- Serum 25(OH)D > 100 ng/mL (250 nmol/L) - confirms vitamin D intoxication; this is the diagnostic marker - Harrison's 22E, p. 1335
- Serum calcium: elevated (hypercalcemia)
- Serum phosphate: elevated (hyperphosphatemia) - renal reabsorption enhanced
- PTH: suppressed (low) - the negative feedback from hypercalcemia suppresses PTH
- 1,25(OH)2D: may be normal or even low in exogenous toxicity (but elevated in granulomatous causes)
- Urinary calcium: increased (hypercalciuria)
Differential Diagnosis
Other causes of hypercalcemia to distinguish from:
- Primary hyperparathyroidism (PTH is elevated, not suppressed)
- Malignancy-associated hypercalcemia (PTHrP elevated)
- Sarcoidosis (1,25(OH)2D elevated, not 25(OH)D primarily)
- Milk-alkali syndrome
- Thiazide diuretics, lithium
- Thyrotoxicosis, pheochromocytoma
Treatment
1. Discontinue vitamin D supplementation - the first and most important step
2. Hydration and dietary calcium restriction
- Restrict calcium intake
- Ensure adequate hydration
- Usually sufficient for mild hypercalcemia
3. Glucocorticoids - the cornerstone of pharmacotherapy for vitamin D-mediated hypercalcemia:
- Prednisone 40-100 mg/day (or equivalent) orally - Harrison's 22E, p. 1335
- Intravenous hydrocortisone 200-400 mg/day for severe cases - Harrison's 22E, p. 488
- Works by: antagonizing vitamin D-stimulated intestinal calcium absorption, decreasing 1,25(OH)2D production, and stimulating renal calcium excretion - Katzung's Pharmacology
- Usually returns serum calcium to normal within several days
4. For severe/acute hypercalcemia:
- IV normal saline (aggressive hydration)
- Loop diuretics (furosemide) after adequate hydration
- Bisphosphonates (inhibit bone resorption) for refractory cases
- Calcitonin for rapid short-term lowering
5. For CYP24A1 mutations:
- Avoidance of sunlight and vitamin D intake
- Reduce calcium intake
- Fluconazole or ketoconazole (CYP27B1 inhibitors) - Harrison's 22E
Important caveat: Because vitamin D is fat-soluble, 25(OH)D stores in adipose tissue can be substantial. Vitamin D intoxication may persist for weeks to months even after discontinuation, requiring prolonged treatment. - Harrison's 22E, p. 1335
Key Distinguishing Points: Exogenous vs. Endogenous
| Feature | Exogenous toxicity | Granulomatous (endogenous) |
|---|---|---|
| Elevated metabolite | 25(OH)D | 1,25(OH)2D |
| PTH | Suppressed | Suppressed |
| 1α-hydroxylase source | Renal (regulated) | Macrophages (unregulated) |
| Responds to steroids | Yes | Yes |
| Cause | Supplement overuse | Sarcoid, TB, lymphoma, etc. |
Sources:
- Harrison's Principles of Internal Medicine 22E (2025), pp. 1331-1335
- Goodman & Gilman's Pharmacological Basis of Therapeutics, p. 208-210
- Fitzpatrick's Dermatology, p. 1585
- Katzung's Basic and Clinical Pharmacology 16e, p. 567
- Goldman-Cecil Medicine, p. 1723-1728
- Quick Compendium of Clinical Pathology 5e, p. 1072-1076
- Yamada's Textbook of Gastroenterology 7e, p. 833-836
Give every answer form Harrison
Searching sources...
Finding Sources
Finding Sources
Found all the relevant Harrison's sections. Now reading them all in parallel.
Reading File
Reading File
Reading File
Good - rich content loaded. Let me read the remaining treatment sections and the vitamin D physiology section from Harrison's.
Reading File
Reading File
Reading File
Excellent - comprehensive Harrison's data loaded. Let me also fetch the vitamin D synthesis diagram.
Loading Image
Reading File
This is a shared conversation. Sign in to Orris to start your own chat.